Return

Bevespi® Aerosphere®

Medication(s):
glycopyrrolate & formoterol fumarate
Mechanism of action:
Combination: Long-Acting Muscarinic Antagonist & Long-Acting β2-Agonist
Doses:
9 mcg/4.8 mcg
Category:
Controller/Maintenance
Type of Device:
Aerosphere®
AAFA Link:
InhalerImage

Some of the photos may depict demonstration inhalers and may not accurately reflect the actual inhaler. Not all images of the medication may be displayed. The medication may appear different. If you have any questions, please consult your pharmacist.

inhalerdatabase.com is not endorsed by any pharmaceutical company or health organization, and the views or opinions expressed herein do not reflect those of any inhaler manufacturers or medical authorities. The names of inhalers and related terminology are trademarks or registered trademarks of their respective patent holders. All content, including texts, images, and data, are presented for informational purposes only and are subject to copyright by the respective rights holders.


© inhalerdatabase.com 2024 - All rights reserved

favicon